FDA Inspection 1103290 — New York Blood Center Inc

New York Blood Center Inc — FEI 3005255747

The FDA completed an inspection of New York Blood Center Inc on August 19, 2019 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 19, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)